Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endogenous gut peptide stimulation refers to the physiological process by which peptides produced within the gastrointestinal (GI) tract are released and act locally or systemically to regulate various aspects of digestion, metabolism, immune response, and tissue repair. Key peptides include GLP-1, GLP-2, CCK, PYY, and ghrelin. These peptides have diverse roles including regulation of appetite and satiety, modulation of insulin secretion and glucose homeostasis, control of gastric emptying and motility, anti-inflammatory effects, and maintenance of mucosal integrity. Endogenous gut proteins also represent a quantitatively large source for bioactive peptide generation through enzymatic cleavage during digestion.
Gut peptides are released into circulation or act locally upon stimulation, binding to specific receptors (primarily GPCRs) to mediate downstream signaling cascades affecting cellular function. Examples: GLP-1 enhances insulin secretion; CCK induces satiety.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endogenous Gut Peptide Stimulation (None).